Omacor (Omega-3-Acid Ethyl Esters 90)

Omega-3-acid ethyl esters, the active ingredient in Omacor, is a omega-3 fatty acid presented as a capsule for oral use. It treats hypertriglyceridemia in adult patients. GNH USA supplies Omacor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omacor, an omega‑3 fatty acid medication, is used to manage disorders of lipid metabolism.

Hypertriglyceridemia: reduces elevated triglyceride concentrations and helps achieve target lipid levels.

Common Side Effects: - Fish‑like aftertaste: a transient metallic or marine taste. - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Diarrhea: loose stools occurring shortly after dosing. - Headache: mild to moderate intensity. - Increased belching: occasional gas‑related symptoms. - Mild rash: occasional skin irritation.

Serious or Rare Side Effects: - Pancreatitis: severe abdominal pain with elevated enzymes. - Bleeding tendency: prolonged bruising or hemorrhage, especially with anticoagulants. - Allergic reactions: urticaria, angioedema, or anaphylaxis. - Elevated liver enzymes: transaminase increases indicating hepatic stress. - Atrial fibrillation: irregular heartbeat reported in rare cases. - Severe hypotension: marked blood pressure drop when combined with antihypertensives.

Before initiating therapy, consider the following precautions: - Triglyceride monitoring: check baseline and periodic levels to assess efficacy. - Liver function: evaluate hepatic enzymes prior to treatment and during therapy. - Fish oil allergy: avoid if the patient has known hypersensitivity to marine oils. - Anticoagulant use: monitor coagulation parameters as bleeding risk may increase. - Pregnancy and breastfeeding: discuss potential risks with a healthcare professional. - Store at ambient temperature: keep capsules in the original container, protect from moisture and excessive heat.

Omacor may interact with several drug classes. Review the following:

Major Interactions (Avoid): - Warfarin or other anticoagulants: increased bleeding risk. - High‑dose aspirin: additive antiplatelet effect. - Other omega‑3 supplements: excess EPA/DHA may amplify adverse effects. - Statins: potential for myopathy when combined with high doses. - Cyclosporine: may raise omega‑3 plasma concentrations.

Moderate Interactions (Monitor Closely): - Antihypertensives: possible additive blood‑pressure lowering. - Oral hypoglycemics: may affect glucose control. - Diuretics: monitor electrolytes if combined. - Immunosuppressants: observe for altered drug levels. - Vitamin E supplements: risk of excessive anticoagulation.